Watch SLXN. Know when insiders buy.
One email the day a filing lands. Free.
SLXN
Silexion Therapeutics Corp
1.98
−0.68 −25.56%
USD · close Nov 13
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $11MP/E 0.3DIV YIELD —FCF YIELD -112.92%REV TTM —NET INCOME −$14MNET CASH —52W 1.98 – 760.08SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose SLXN in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
Moringa Sponsor, LP and 2 related17.7%
“The information contained in Item 3 is incorporated by reference in its entirety into this Item 4. On June 22, 2026, Moringa Sponsor, LP filed a claim against Silexion Therapeutics Corp and two of its senior officers (the "Claim"), alleging deliberate and systematic breaches of the Amended and Resta…”
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.